Please assess the completion status of the following clinical trial:

Trial Title: Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Critically ill adult patient (≥ 18 years) admitted to ICU~* Has acute respiratory failure (ARF) i.e. expected to remain mechanically ventilated for more than 48 hours~* Expected ICU dependency of 5 or more days~* On or expected to initiate enteral nutrition within 7 days of ICU admission~* BMI \<25 or ≥ 35 based on pre-ICU actual or estimated dry weight~Exclusion Criteria:~* \>72 hours from admission to ICU to time of consent~* Not expected to survive an additional 48 hrs from screening evaluation~* A lack of commitment to full aggressive care (anticipated withholding or withdrawing treatments in the first week but isolated DNR acceptable)~* Patients already receiving PN at screening~* Absence of All gastrointestinal risk factors, defined as:~  1. High Apache II Score (\>20)~ 2. On more than 1 vasopressor or increasing doses or vasopressors~ 3. Receiving continuous infusion of narcotics~ 4. High nasogastric/orogastric output (\>500 mL over 24 hours)~ 5. Recent surgery involving esophagus, stomach, or small bowel OR peritoneal contamination with bowel contents~ 6. Pancreatitis~ 7. Multiple gastrointestinal investigations~ 8. Recent history of diarrhea/C. Difficile~ 9. Surgical patients with future surgeries planned~ 10. Ruptured or dissected abdominal aortic aneurysm~* Patients admitted with diabetic ketoacidosis or non-ketotic hyperosmolar coma~* Pregnant or lactating patients~* Patients with clinical fulminant hepatic failure~* Patients with Cirrhosis Child's Class C Liver Disease (except those on a transplant list or transplantable)~* Dedicated port of central line not available~* Known allergy to study nutrients (soy, eggs or olive products)~* Enrolment in another industry sponsored ICU intervention study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Enteral Nutrition + Parenteral Nutrition (Type: EXPERIMENTAL): Enteral nutrition with the addition of parenteral supplementation (Olimel 5.7%E/N9E).
- Enteral Nutrition Only (Type: NO_INTERVENTION): Enteral nutrition only - no intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).